Authors
Latest:
Is There an Alternative to PBM Rebates? ICER Paper Examines 3 OptionsWith discussion and debate happening for months in Washington, DC, over drug pricing and the role of pharmacy benefit managers (PBMs), the Institute for Clinical and Economic Review (ICER) published a white paper this week that analyzes 3 possible alternatives to the pharmaceutical rebate system fostered by PBMs.
Latest:
Care Coordination in a New Health Care Model: Improving Outcomes for Patients with DiabetesAvoiding unnecessary utilization of hospitals, improving quality of care, and establishing continuous chronic disease management.
Latest:
Special Specialty Pharmacies: Differentiation from CompetitionRemaining special in the specialty pharmacy space requires innovation.
Latest:
Quality Initiatives: Pharmacists in the ForefrontPharmacists can lead quality transformation within their organizations.
Latest:
Considerations for Specialty Pharmacy as Enforcement on Controlled Substances Ramps Up to Counter Opioid CrisisState regulators and legislatures are considering new requirements for controlled substance prescribing and reporting.
Latest:
Patterns of Specific Testing for Patients With Chronic Myelogenous LeukemiaStudy assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Janssen Pharmaceuticals' XareltoThe FDA approved Xarelto (rivaroxaban) for the prevention of venous thromboembolism following hip or knee replacements and for the prevention of stroke in patients with nonvalvular atrial fibrillation.
Latest:
Your Personal Brand: Education and Experience in Pharmacy InformaticsPharmacy informatics specialists are in high demand.
Latest:
Malignant Hyperthermia, Dantrolene, and the PharmacistMalignant hyperthermia can result in a rare anesthetic emergency and can be fatal.
Latest:
Can Multivitamins Curb Hypertension?Little is known about multivitamin use and associated prevention or development of hypertension, especially in women.
Latest:
Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and OutcomesThis study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.
Latest:
The Dawn of Scaleable Behavioral Diagnostics in Health CareThroughout the world, patients and health care professionals alike have become better acquainted with digital tools when face-to-face interactions became increasingly problematic.
Latest:
Opinion: Coronavirus Impact on Pharmacy Students in APPE RotationsThree student pharmacists share their experiences adapting to APPE rotations during the COVID-19 pandemic,
Latest:
AfrezzaNearly 30% of patients with diabetes have reported that injectable insulin was the most difficult part of their care regimen.
Latest:
How to Balance Treatment Risk, Benefit in Older Patients With CancerA standard chronological definition for older adults in oncology would be beneficial.
Latest:
Optimizing Care for Orphan Diseases With Pulmonary Issues During COVID-19 PandemicThe value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.
Latest:
Help Patients Using Opioids Avoid StigmaGiven the evidence of emotional trauma, hopelessness, and social isolation as risk factors for addiction, compassion and support are critical.
Latest:
Manufacturer Considerations for Designing a Distribution Strategy for Specialty ProductsAs health care costs continue to increase, and with high-cost specialty products making up a significant portion of the pipeline, the role of the Specialty Pharmacy (SP) continues to grow and influence health care decisions across multiple stakeholders.
Latest:
Treatment and Outcomes Data Are Evolving for Patients With COVID-19 and CancerThe CDC recommends that patients with cancer and COVID-19 have a conversation with their health care provider or care team to discuss the individual level of risk based on the patient’s current condition, treatment, and the level of transmission within their community.
